CSE New #Cannabis Stock Listing: Ascent Industries Corp. (ASNT)
 
August 8, 2018 (Investorideas.com Newswire) The common shares of Ascent Industries Corp., previously listed as Paget Minerals Corp. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. In Canada, Ascent (through its wholly-owned subsidiaries) is a Licenced Producer under the Access to Cannabis for Medical Purposes Regulations of Health Canada, with licences to cultivate cannabis and produce cannabis extracts. In addition, the Company is a Licenced Dealer under the Controlled Drugs and Substances Act (Canada), with the ability to produce, package, sell, send, transport and distribute medically focused cannabis products in Canada to other licenced entities and internationally in jurisdictions where medical cannabis is legal. In the United States, the Company holds licences in Oregon (for processing and for distribution of cannabis to any licenced entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary of Ascent, has submitted licence applications for a Wholesaler Dealers Licence and Controlled Drug Licence in Denmark, and applications for the approval of eight products to the Danish Medical Cannabis Pilot Program. ________________________
Les actions ordinaires de Ascent Industries Corp., auparavant inscrites à titre de Paget Minerals Corp., ont été approuvées apour inscription à la cote du CSE. Les documents d'inscription et de divulgation seront disponibles sur www.thecse.com à la date de négociation. Au Canada, Ascent (par l'intermédiaire de ses filiales en propriété exclusive) est un producteur autorisé en vertu du Règlement sur l'accès au cannabis à des fins médicales de Santé Canada, avec des licences pour cultiver du cannabis et produire des extraits de cannabis. En outre, la Société est un distributeur agréé en vertu de la Loi réglementant certaines drogues et autres substances (Canada), capable de produire, d’emballer, de vendre, d’envoyer, de transporter et de distribuer des produits du cannabis le cannabis médical est légal. Aux États-Unis, la Société détient des licences en Oregon (pour le traitement et la distribution de cannabis à toute entité autorisée dans l'État) et au Nevada (pour la culture et la production, la transformation et la distribution en gros de cannabis). En Europe, Agrima ApS, une société danoise et filiale à 100% d'Ascent, a présenté des demandes de licence pour une licence de grossiste et une licence contrôlée au Danemark, ainsi que des demandes d'approbation de huit produits au programme pilote danois de cannabis médical. If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse:  Listings@thecse.com
Investorideas.com is a Canadian Securities Exchange (CSE) Service Provider; Cannabis stocks, Blockchain stocks, Mining, E-sports, Energy, Biotech and more...

CSE New #Cannabis Stock Listing: Ascent Industries Corp. (ASNT)

News provided by
Share this article
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./
VANCOUVER, Aug. 7, 2018 /CNW/ - On July 26, 2018, Ascent Industries Corp. ("Ascent" or the "Company") held a special meeting (the "Meeting") of its shareholders to consider the proposed amalgamation (the "Amalgamation") of the Company and Paget Minerals Corp. ("Paget"), in connection with a proposed public listing of the amalgamated company ("Amalco") on the Canadian Securities Exchange (the "CSE") as previously announced. The Company is pleased to announce that the Amalgamation was approved by all the shareholders of Ascent at the Meeting. In addition, at a meeting of the shareholders of Paget held immediately after the Meeting of Ascent shareholders, the shareholders of Paget also overwhelmingly approved the Amalgamation, as well as the delisting of Paget from the NEX board of the TSX Venture Exchange. On August 3, 2018, Ascent received written notification from the CSE that Amalco has been conditionally approved for listing on the CSE, subject to the completion of outstanding CSE application documentation and the payment of fees. The CSE has confirmed that Amalco will begin trading on August 9, 2018, under the symbol "ASNT". Results of Special Meeting of Shareholders
Shareholders of Ascent voted 100% in favour of the Amalgamation, while shareholders of Paget supported the Amalgamation with greater than 99% in favour. The successful completion of the Meeting and support for the Amalgamation marks the successful conclusion of one of the final critical steps in Ascent's go-public process. Philip Campbell, Ascent's CEO, remarked "We at Ascent are extremely excited to begin the next phase of our growth, becoming a publicly traded company with the resulting liquidity for our shareholders, and expanded access to capital as we continue to grow. We plan to continue to meet challenges head-on as we steadily build out our business under the leadership of what we believe is a world class management team in the cannabis industry." Philip Campbell added "On behalf of Ascent, I am grateful to all our shareholders for their long-term support for the Company. I would also like to express my appreciation to all of our various partners who have helped us reach this day – capital providers, industry partners, advisors, and especially employees. I am looking forward to building value for all stakeholders as a public company." Ascent Receives Conditional Listing Approval from CSE
On July 31, 2018, the CSE provided the Company with a conditional listing approval letter in respect of Amalco. On August 3rd, the Company gained access to the funds raised by the Company in the previously completed subscription receipt offering for gross proceeds of approximately $19.2 million. Furthermore, upon completion of the Amalgamation, the proceeds from the private placement totaling approximately $2.4 million recently completed by Paget will also become available. The Amalgamation will be completed and the Amalco shares will begin trading on Aug 9th, 2018 under the ticket "ASNT". Management Update
Ascent would also like to announce certain changes to its executive management team. Philip Campbell, Chief Executive Officer, is pleased to announce that Blair Jordan, previously VP Corporate Development for Ascent, assumed the role of Chief Financial Officer of Ascent on August 3, 2018. Mr. Jordan was instrumental in arranging and structuring the Amalgamation, and the concurrent financing of approximately $19 million. He has significant capital markets experience, having been Managing Director at Echelon Wealth Partners Inc. in Canada for five years prior to joining Ascent, and in a variety of international roles with Credit Suisse Group for the previous nine years. Mr. Jordan holds an MBA from the Booth School of Business at the University of Chicago and an LLB from the University of British Columbia School of Law. Pam Boparai, the Corporation's former Chief Financial Officer, resigned effective August 3, 2018, to resume her professional consulting practice. Pam played an integral role in preparing the Company for the go-public process, and Ascent and the Board of Directors would like to thank Pam for her hard work, dedication and contributions to Ascent. Further Information
All information contained in this news release with respect to Ascent and Paget was supplied by the parties respectively, for inclusion herein, and each party and its directors and officers have relied on the other party for any information concerning the other party. About Ascent Industries Corp. In Canada, Ascent (through its wholly-owned subsidiaries) is a Licenced Producer under the Access to Cannabis for Medical Purposes Regulations of Health Canada, with licences to cultivate cannabis and produce cannabis extracts. In addition, the Company is a Licenced Dealer under the Controlled Drugs and Substances Act (Canada), with the ability to produce, package, sell, send, transport and distribute medically focused cannabis products in Canada to other licenced entities and internationally in jurisdictions where medical cannabis is legal. In the United States, the Company holds licences in Oregon (for processing and for distribution of cannabis to any licenced entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary of Ascent, has submitted licence applications for a Wholesaler Dealers Licence and Controlled Drug Licence in Denmark, and applications for the approval of eight products to the Danish Medical Cannabis Pilot Program. The Company's operations currently include licenced facilities in British Columbia, Canada, and in Oregon and Nevada in the United States. The Company is increasing its cultivation and production capacity from 50,000 square feet to 710,000 square feet in 2018, from which it expects to produce significantly higher amounts of cannabis and cannabis oil to support its expanding operations. The Company offers a product suite of more than 40 unique products under several consumer-focused brands, including gel capsules, tinctures, medicinal oils, concentrates, vaporizer pens, pre-rolled joints, various edibles and raw flower. Through careful development of its sophisticated cannabis brands, Ascent is positioned to be a leader in branded, commercialized products in both medical and adult-use markets across North America and internationally. In addition, the Company conducts cannabis-based research with Simon Fraser University and the University of Kentucky, including in the area of unique cannabinoid formulations that produce targeted physiological outcomes. Completion of the Amalgamation and listing is subject to a number of conditions, including but not limited to, final acceptance from the CSE. There can be no assurance that the Amalgamation or listing will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the management information circular or listing statement to be prepared in connection with the Amalgamation and listing, any information released or received with respect to the Amalgamation and listing may not be accurate or complete and should not be relied upon. This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Neither TSXV nor the CSE has in any way passed upon the merits of the proposed Transaction or the listing of the shares of the amalgamated entity and has neither approved nor disapproved the contents of this press release. NEITHER THE TSXV OR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV), NOR THE CSE OR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the terms and conditions of the proposed Transaction and Amalgamation and the completion and timing thereof. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Paget and Ascent assume no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. SOURCE Ascent Industries
For further information:  Philip Campbell, Chief Executive Officer and Director, Ascent, Telephone: 1.604.928.2988, Email: philip@ascentindustriescorp.com; Mark Brown, Chief Executive Officer, Paget Minerals Corp., Telephone: 604-687-3520, Email: mtbrown@pacificopportunity.com
Organization Profile

Ascent Industries Corp. & Paget Minerals Corp. Announce Results of Special Meeting of Shareholders, Conditional Approval from the Canadian Securities Exchange and Management Update

| Source: Paget Minerals Corp.
VANCOUVER, British Columbia, Aug.  07, 2018  (GLOBE NEWSWIRE) --
Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. On July 26, 2018, Ascent Industries Corp. (“Ascent" or the “Company”) held a special meeting (the "Meeting”) of its shareholders to consider the proposed amalgamation (the “Amalgamation”) of the Company and Paget Minerals Corp. (NEX: PGS.H)  (“Paget”), in connection with a proposed public listing of the amalgamated company (“Amalco”) on the Canadian Securities Exchange (the “CSE”) as previously announced. The Company is pleased to announce that the Amalgamation was approved by all the shareholders of Ascent at the Meeting. In addition, at a meeting of the shareholders of Paget held immediately after the Meeting of Ascent shareholders, the shareholders of Paget also overwhelmingly approved the Amalgamation, as well as the delisting of Paget from the NEX board of the TSX Venture Exchange. On August 3, 2018, Ascent received written notification from the CSE that Amalco has been conditionally approved for listing on the CSE, subject to the completion of outstanding CSE application documentation and the payment of fees. The CSE has confirmed that Amalco will begin trading on August 9, 2018, under the symbol “ASNT”. Results of Special Meeting of Shareholders
Shareholders of Ascent voted 100% in favour of the Amalgamation, while shareholders of Paget supported the Amalgamation with greater than 99% in favour. The successful completion of the Meeting and support for the Amalgamation marks the successful conclusion of one of the final critical steps in Ascent’s go-public process. Philip Campbell, Ascent’s CEO, remarked “We at Ascent are extremely excited to begin the next phase of our growth, becoming a publicly traded company with the resulting liquidity for our shareholders, and expanded access to capital as we continue to grow. We plan to continue to meet challenges head-on as we steadily build out our business under the leadership of what we believe is a world class management team in the cannabis industry.”
Philip Campbell added “On behalf of Ascent, I am grateful to all our shareholders for their long-term support for the Company. I would also like to express my appreciation to all of our various partners who have helped us reach this day – capital providers, industry partners, advisors, and especially employees. I am looking forward to building value for all stakeholders as a public company.”
Ascent Receives Conditional Listing Approval from CSE
On July 31, 2018, the CSE provided the Company with a conditional listing approval letter in respect of Amalco. On August 3rd, the Company gained access to the funds raised by the Company in the previously completed subscription receipt offering for gross proceeds of approximately $19.2 million. Furthermore, upon completion of the Amalgamation, the proceeds from the private placement totaling approximately $2.4 million recently completed by Paget will also become available. The Amalgamation will be completed and the Amalco shares will begin trading on Aug 9th, 2018 under the ticket “ASNT”. Management Update
Ascent would also like to announce certain changes to its executive management team. Philip Campbell, Chief Executive Officer, is pleased to announce that Blair Jordan, previously VP Corporate Development for Ascent, assumed the role of Chief Financial Officer of Ascent on August 3, 2018. Mr. Jordan was instrumental in arranging and structuring the Amalgamation, and the concurrent financing of approximately $19 million. He has significant capital markets experience, having been Managing Director at Echelon Wealth Partners Inc. in Canada for five years prior to joining Ascent, and in a variety of international roles with Credit Suisse Group for the previous nine years. Mr. Jordan holds an MBA from the Booth School of Business at the University of Chicago and an LLB from the University of British Columbia School of Law. Pam Boparai, the Corporation’s former Chief Financial Officer, resigned effective August 3, 2018, to resume her professional consulting practice. Pam played an integral role in preparing the Company for the go-public process, and Ascent and the Board of Directors would like to thank Pam for her hard work, dedication and contributions to Ascent. Further Information
All information contained in this news release with respect to Ascent and Paget was supplied by the parties respectively, for inclusion herein, and each party and its directors and officers have relied on the other party for any information concerning the other party. For further information, please contact:
Philip Campbell, Chief Executive Officer and Director, Ascent. Telephone:        1.604.928.2988
Telephone:        604-687-3520
About Ascent Industries Corp. In Canada, Ascent (through its wholly-owned subsidiaries) is a Licenced Producer under the Access to Cannabis for Medical Purposes Regulations of Health Canada, with licences to cultivate cannabis and produce cannabis extracts. In addition, the Company is a Licenced Dealer under the Controlled Drugs and Substances Act (Canada), with the ability to produce, package, sell, send, transport and distribute medically focused cannabis products in Canada to other licenced entities and internationally in jurisdictions where medical cannabis is legal. In the United States, the Company holds licences in Oregon (for processing and for distribution of cannabis to any licenced entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary of Ascent, has submitted licence applications for a Wholesaler Dealers Licence and Controlled Drug Licence in Denmark, and applications for the approval of eight products to the Danish Medical Cannabis Pilot Program. The Company's operations currently include licenced facilities in British Columbia, Canada, and in Oregon and Nevada in the United States. The Company is increasing its cultivation and production capacity from 50,000 square feet to 710,000 square feet in 2018, from which it expects to produce significantly higher amounts of cannabis and cannabis oil to support its expanding operations. The Company offers a product suite of more than 40 unique products under several consumer-focused brands, including gel capsules, tinctures, medicinal oils, concentrates, vaporizer pens, pre-rolled joints, various edibles and raw flower. Through careful development of its sophisticated cannabis brands, Ascent is positioned to be a leader in branded, commercialized products in both medical and adult-use markets across North America and internationally. In addition, the Company conducts cannabis-based research with Simon Fraser University and the University of Kentucky, including in the area of unique cannabinoid formulations that produce targeted physiological outcomes. Completion of the Amalgamation and listing is subject to a number of conditions, including but not limited to, final acceptance from the CSE. There can be no assurance that the Amalgamation or listing will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the management information circular or listing statement to be prepared in connection with the Amalgamation and listing, any information released or received with respect to the Amalgamation and listing may not be accurate or complete and should not be relied upon. This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Neither TSXV nor the CSE has in any way passed upon the merits of the proposed Transaction or the listing of the shares of the amalgamated entity and has neither approved nor disapproved the contents of this press release. NEITHER THE TSXV OR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV), NOR THE CSE OR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the terms and conditions of the proposed Transaction and Amalgamation and the completion and timing thereof. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, Paget and Ascent assume no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. Related Articles

Ascent Industries Corp. & Paget Minerals Corp. Announce Results of Special Meeting of Shareholders, Conditional Approval From the Canadian Securities Exchange and Management Update

Announce Results of Special Meeting of Shareholders, Conditional Approval from the Canadian Securities Exchange and Management Update
VANCOUVER, Aug. 7, 2018 /CNW/ – On July 26, 2018, Ascent Industries Corp. (“Ascent” or the “Company”) held a special meeting (the “Meeting”) of its shareholders to consider the proposed amalgamation (the “Amalgamation”) of the Company and Paget Minerals Corp. (“Paget”), in connection with a proposed public listing of the amalgamated company (“Amalco”) on the Canadian Securities Exchange (the “CSE”) as previously announced. The Company is pleased to announce that the Amalgamation was approved by all the shareholders of Ascent at the Meeting. In addition, at a meeting of the shareholders of Paget held immediately after the Meeting of Ascent shareholders, the shareholders of Paget also overwhelmingly approved the Amalgamation, as well as the delisting of Paget from the NEX board of the TSX Venture Exchange. On August 3, 2018, Ascent received written notification from the CSE that Amalco has been conditionally approved for listing on the CSE, subject to the completion of outstanding CSE application documentation and the payment of fees. The CSE has confirmed that Amalco will begin trading on August 9, 2018, under the symbol “ASNT”. Results of Special Meeting of Shareholders
Shareholders of Ascent voted 100% in favour of the Amalgamation, while shareholders of Paget supported the Amalgamation with greater than 99% in favour. The successful completion of the Meeting and support for the Amalgamation marks the successful conclusion of one of the final critical steps in Ascent’s go-public process. We at Ascent are extremely excited to begin the next phase of our growth, becoming a publicly traded company with the resulting liquidity for our shareholders, and expanded access to capital as we continue to grow. Philip Campbell, Ascent’s CEO
We plan to continue to meet challenges head-on as we steadily build out our business under the leadership of what we believe is a world class management team in the cannabis industry. Philip Campbell added “On behalf of Ascent, I am grateful to all our shareholders for their long-term support for the Company. I would also like to express my appreciation to all of our various partners who have helped us reach this day – capital providers, industry partners, advisors, and especially employees. I am looking forward to building value for all stakeholders as a public company.”
Ascent Receives Conditional Listing Approval from CSE
On July 31, 2018, the CSE provided the Company with a conditional listing approval letter in respect of Amalco. On August 3rd, the Company gained access to the funds raised by the Company in the previously completed subscription receipt offering for gross proceeds of approximately $19.2 million. Furthermore, upon completion of the Amalgamation, the proceeds from the private placement totaling approximately $2.4 million recently completed by Paget will also become available. The Amalgamation will be completed and the Amalco shares will begin trading on Aug 9th, 2018 under the ticket “ASNT”. Management Update
Ascent would also like to announce certain changes to its executive management team. Philip Campbell, Chief Executive Officer, is pleased to announce that Blair Jordan, previously VP Corporate Development for Ascent, assumed the role of Chief Financial Officer of Ascent on August 3, 2018. Mr. Jordan was instrumental in arranging and structuring the Amalgamation, and the concurrent financing of approximately $19 million. He has significant capital markets experience, having been Managing Director at Echelon Wealth Partners Inc. in Canada for five years prior to joining Ascent, and in a variety of international roles with Credit Suisse Group for the previous nine years. Mr. Jordan holds an MBA from the Booth School of Business at the University of Chicago and an LLB from the University of British Columbia School of Law. Pam Boparai, the Corporation’s former Chief Financial Officer, resigned effective August 3, 2018, to resume her professional consulting practice. Pam played an integral role in preparing the Company for the go-public process, and Ascent and the Board of Directors would like to thank Pam for her hard work, dedication and contributions to Ascent. Further Information
All information contained in this news release with respect to Ascent and Paget was supplied by the parties respectively, for inclusion herein, and each party and its directors and officers have relied on the other party for any information concerning the other party. About Ascent Industries Corp. In Canada, Ascent (through its wholly-owned subsidiaries) is a Licenced Producer under the Access to Cannabis for Medical Purposes Regulations of Health Canada, with licences to cultivate cannabis and produce cannabis extracts. In addition, the Company is a Licenced Dealer under the Controlled Drugs and Substances Act (Canada), with the ability to produce, package, sell, send, transport and distribute medically focused cannabis products in Canada to other licenced entities and internationally in jurisdictions where medical cannabis is legal. In the United States, the Company holds licences in Oregon (for processing and for distribution of cannabis to any licenced entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary of Ascent, has submitted licence applications for a Wholesaler Dealers Licence and Controlled Drug Licence in Denmark, and applications for the approval of eight products to the Danish Medical Cannabis Pilot Program. The Company’s operations currently include licenced facilities in British Columbia, Canada, and in Oregon and Nevada in the United States. The Company is increasing its cultivation and production capacity from 50,000 square feet to 710,000 square feet in 2018, from which it expects to produce significantly higher amounts of cannabis and cannabis oil to support its expanding operations. The Company offers a product suite of more than 40 unique products under several consumer-focused brands, including gel capsules, tinctures, medicinal oils, concentrates, vaporizer pens, pre-rolled joints, various edibles and raw flower. Through careful development of its sophisticated cannabis brands, Ascent is positioned to be a leader in branded, commercialized products in both medical and adult-use markets across North America and internationally. In addition, the Company conducts cannabis-based research with Simon Fraser University and the University of Kentucky, including in the area of unique cannabinoid formulations that produce targeted physiological outcomes.

Global Cannabis Operator Ascent Industries to Commence Trading on the CSE

Not for distribution to United States newswire services or for release publication,
distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, June  25, 2018  (GLOBE NEWSWIRE) -- Paget Minerals Corp. (NEX:PGS.H) ("Paget" or the “Company”) is pleased to announce that it entered into an amended letter of intent on June 20, 2018 (the “Amended LOI”) with Ascent Industries Corp. (“Ascent”) in connection with the previously announced reverse take-over of Paget by Ascent by way of the amalgamation of Paget and Ascent (the “Amalgamation”) to form an amalgamated corporation (“Amalco”) and listing of Amalco on the Canadian Securities Exchange (“CSE”), expected to be completed late July or early August 2018. The Amended LOI provides that Paget will raise up to $2 million by way of a private placement of units at a price of $0.05 per unit (the “Private Placement”), prior to the completion of the Amalgamation. Each unit will consist of one common share (a “Paget Share”) and one common share purchase warrant exercisable to purchase one Paget Share for a period of two years from the date of issue at $0.10 per warrant. Paget shall be entitled to accelerate the expiry of the warrants if the 20 day VWAP of the Paget Shares is equal to or greater than $0.10. It is intended that the Private Placement will be completed after the shareholders of Paget have approved the delisting of the common shares from the NEX Board of the TSX Venture Exchange. The Company intends on using the proceeds from the Private Placement to carry out the Amalgamation and for general corporate purposes. Pursuant to the terms of the Amalgamation, all securities of Paget outstanding immediately prior to the Amalgamation will be consolidated on a six (6) for one basis (the “Consolidation”), and holders of Paget Shares will receive one common share of Amalco (an “Amalco Share”) for each post-Consolidation Paget Share held and holders of securities convertible into Paget Shares will receive an equivalent security of Amalco on an equivalent basis. Holders of common shares of Ascent (an “Ascent Share”) will receive one Amalco Share for each Ascent Share held and holders of securities convertible into Ascent Shares will receive an equivalent security of Amalco on an equivalent basis. Ascent has recently closed a $19.2 million financing which was announced on June 21, 2018. Further Information
Further information regarding the Ascent Industries Corp. transaction can be found in the Company’s news release dated April 30, 2018, a copy of which is available on the Company’s website at www.pagetminerals.com . Mark T. Brown, Chief Executive Officer, Paget Minerals Corp.
Telephone:
mtbrown@pacificopportunity.com
This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. The NEX has not in any way passed upon the merits of the Private Placement and has neither approved nor disapproved the contents of this press release. NEITHER THE TSXV OR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate, among other things, to: the terms and conditions of the Agreement and the closing of the transaction thereunder; the terms and condition of the Amalgamation and the closing thereof, the terms and conditions of the private placement; and the use of funds under the financings. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and the delay or failure to receive board, shareholder or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. The terms and conditions of the Agreement, the private placement and the Amalgamation may change based on the parties' due diligence (which in the case of Paget is going to be limited as Paget intends largely to rely on the due diligence of other parties of the transaction to contain its costs, among other things) and the receipt of tax, corporate and securities law advice for each of the parties. Except as required by law, Paget and Ascent assume no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. Related Articles

Paget Minerals Corp. Private Placement and RTO Update

Acq - Fin

Paget Minerals focuses on mineral exploration and the advancement of the company's priority Ball Creek Project. In February 2012, Paget Minerals was acquired by Pinetree Capital. The valuation of Paget Minerals was undisclosed. Other terms of the deal were not released.

Wells Fargo Success Story

Professional Services

Platform Overview

Paget Minerals

Compete with Paget Minerals?

Compete with Paget Minerals?

Discover the right solution for your team